Expanded Programme on Immunization (EPI)

Expanded Programme on Immunization (EPI)
Name	Expanded Programme on Immunization
Founded	1974
Founder	World Health Organization
Type	International public health programme
Region	Global
Purpose	Universal childhood vaccination

Expanded Programme on Immunization (EPI)

The Expanded Programme on Immunization (EPI) is a global public health initiative launched to increase access to vaccines for children and prevent vaccine-preventable diseases. Initiated by World Health Organization and implemented with partners such as United Nations Children's Fund and Gavi, the Vaccine Alliance, EPI has driven routine immunization policies, cold chain systems, and surveillance frameworks across countries and regions. Its activities intersect with national ministries such as the Ministry of Health (United Kingdom), Ministry of Health and Family Welfare (India), and international bodies including the Centers for Disease Control and Prevention.

History and development

EPI was established in 1974 by the World Health Assembly following deliberations involving delegations from United States, United Kingdom, France, India, and Brazil and advocacy by figures linked to Albert B. Sabin and Jonas Salk. Early trials and campaigns drew on precedents such as the Smallpox Eradication Programme and immunization activities by Rotary International and League of Nations-era initiatives. In the 1980s and 1990s partnerships expanded to include United Nations Development Programme, World Bank, and later Gavi, the Vaccine Alliance in 2000, integrating financing models used by International Monetary Fund-supported programmes. Major milestones include the incorporation of new antigens following recommendations from advisory groups like the Strategic Advisory Group of Experts on Immunization and global elimination goals articulated at forums such as the World Health Assembly and World Summit for Children.

Objectives and target diseases

EPI’s stated objectives align with resolutions from the World Health Assembly and guidance from Global Alliance for Vaccines and Immunization stakeholders: reduce morbidity and mortality from vaccine-preventable diseases, achieve high routine immunization coverage, and introduce new vaccines into national schedules. Target diseases have historically included diphtheria, tetanus, pertussis, poliomyelitis, measles, and tuberculosis (via BCG vaccine), with later additions such as Haemophilus influenzae type b, hepatitis B, pneumococcal disease, and rotavirus following advisory endorsements and licensure decisions by regulators like the European Medicines Agency and the United States Food and Drug Administration.

Implementation and delivery strategies

Implementation is carried out through collaborations among national health ministries, regional bodies such as the Pan American Health Organization, and operational partners including Médecins Sans Frontières, Save the Children, and Red Cross and Red Crescent Movement. Delivery strategies encompass routine immunization clinics, mass campaigns exemplified by national pulse campaigns in India and mop-up campaigns during polio eradication efforts in Nigeria and Pakistan, and integration with maternal and child health platforms like antenatal services promoted in Bangladesh and Rwanda. Financing models combine domestic budgets, Gavi, the Vaccine Alliance grants, and multilateral loans from the World Bank; procurement systems rely on pooled procurement mechanisms used by UNICEF Supply Division and national tendering processes.

Vaccines and cold chain logistics

EPI’s vaccine schedules incorporate formulations endorsed by the World Health Organization and licensed by national regulators such as Health Canada and the Ministry of Health, Labour and Welfare (Japan). Cold chain logistics depend on technologies and suppliers associated with entities like UNICEF and manufacturers including GlaxoSmithKline, Pfizer, Sanofi, and Serum Institute of India. Infrastructure components—refrigerators, cold boxes, temperature monitors—are often procured through partnerships with organizations like the Global Fund and supported by standards from the International Organization for Standardization. Innovations such as solar-powered refrigerators and controlled-temperature chain pilots have been implemented in settings ranging from remote districts in Ethiopia to archipelagos in Philippines.

Monitoring, evaluation, and coverage metrics

Monitoring frameworks use indicators endorsed at the World Health Assembly and methodologies from agencies including UNICEF and the Demographic and Health Surveys Program. Coverage metrics such as DTP3 (diphtheria, tetanus, pertussis third dose) and measles-containing vaccine coverage are tracked through national immunization registers, sentinel surveillance sites, and serosurveys conducted with technical support from Centers for Disease Control and Prevention. Evaluation employs epidemiological tools used in Global Polio Eradication Initiative assessments and cost-effectiveness analyses reminiscent of studies by the Institute for Health Metrics and Evaluation.

Challenges and criticisms

EPI faces challenges including vaccine hesitancy observed in settings influenced by political actors like Donald Trump-era rhetoric or media platforms exemplified by controversies involving Facebook and Twitter, supply chain constraints linked to manufacturing capacity at firms like BioNTech and Moderna, and financing gaps highlighted by analyses from the World Bank and International Monetary Fund. Criticisms address equity concerns raised by advocacy groups such as Amnesty International and Oxfam, debates over intellectual property framed by World Trade Organization negotiations, and operational shortcomings documented in country reviews by Transparency International and academic journals including articles in The Lancet.

Global impact and country case studies

EPI-associated initiatives contributed to the global reduction of diseases, with near-eradication of poliomyelitis in many regions and dramatic declines in measles mortality reported across Sub-Saharan Africa, South Asia, and the Americas. Country case studies include the successful scale-up in Rwanda that integrated community health worker networks, the high-coverage programs in Cuba supported by the Cuban Ministry of Public Health, and the challenges of sustaining coverage in conflict-affected areas such as Syria and Yemen. Evaluations at venues like the World Health Assembly continue to shape EPI priorities amid evolving threats and advances in vaccine science.

Category:Public health